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ProteaseSome nematode species are economically important parasites of livestock, while others are important
human pathogens causing some of the most important neglected tropical diseases. In both humans
and animals, anthelmintic drug administration is the main control strategy, but the emergence of
drug-resistant worms has stimulated the development of alternative control approaches. Among these,
vaccination is considered to be a sustainable and cost effective strategy. Currently, Barbervax for the
ruminant strongylid Haemonchus contortus is the only registered subunit vaccine for a nematode parasite,
although a vaccine for the human hookworm Necator americanus is undergoing clinical trials (HOOKVAC
consortium). As both these vaccines comprise a limited number of proteins, there is potential for selec-
tion of nematodes with altered sequences or expression of the vaccine antigens. Here we compared the
transcriptome of H. contortus populations from sheep vaccinated with Barbervax with worms from con-
trol animals. Barbervax antigens are native integral membrane proteins isolated from the brush border
of the intestinal cells of the adult parasite and many of those are proteases. Our findings provide no evi-
dence for changes in expression of genes encoding Barbervax antigens in the surviving parasite popu-
lations. However, surviving parasites from vaccinated animals showed increased expression of other
proteases and regulators of lysosome trafficking, and displayed up-regulated lipid storage and defecation
abilities that may have circumvented the effect of the vaccine. Implications for other potential vaccines
for human and veterinary nematodes are discussed.
 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Gastrointestinal nematodes (GINs) are clinically and economi-
cally important parasites of humans (Hotez et al., 2016) and live-
stock species (Kaplan and Vidyashankar, 2012), hence impeding
both human health and wealth (Rist et al., 2015). Control of veteri-
nary parasites has relied primarily on strategic drug administration
(McKellar and Jackson, 2004). However the increase in anthelmin-
tic resistance, particularly multidrug resistance, threatens theviability of the livestock industry in many regions of the world
(Kaplan and Vidyashankar, 2012). Similarly, suboptimal anthel-
minthic efficacy has been reported for human ascarids (Krücken
et al., 2017) and hookworms (Keiser and Utzinger, 2008;
Soukhathammavong et al., 2012).
It is unlikely that novel anthelmintic compounds will be
approved at an equivalent pace to the emergence of anthelmintic
resistance (Geary et al., 2004). Greater research efforts are there-
fore being directed at vaccine development for more sustainable
GIN control in both veterinary and human settings (Hewitson
and Maizels, 2014; Hotez et al., 2016). Vaccines may be used alone
or combined with drug treatment to reduce the emergence of drug
resistance (Lee et al., 2011). In comparison with antimicrobial
drugs, there are few examples of the development of resistance
to vaccination in bacterial or viral pathogens (Kennedy and Read,
2017). However, the antigenic complexity and immunoregulatory
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lenging (Hewitson and Maizels, 2014). Only two vaccines are cur-
rently commercially available: Barbervax licensed in Australia in
2014 and comprising native parasite gut membrane glycoproteins
of the ovine GIN Haemonchus contortus (Bassetto and Amarante,
2015; Kearney et al., 2016), and Bovilis huskvac, an irradiated lar-
val vaccine for the cattle lungworm Dictyocaulus viviparus
(McKeand, 2000).
Digestion of haemoglobin in haematophagous nematodes such
as H. contortus requires activity of different proteolytic enzymes
including aspartic, cysteine and metallo-proteases and exopepti-
dases (Williamson et al., 2003), underscoring the large expansion
of protease gene families identified within the genome of H. contor-
tus (Laing et al., 2013; Schwarz et al., 2013). Barbervax is prepared
from gut membrane extracts of H. contortus adult worms and con-
tains two major protease fractions, H11 and H-gal-GP (Smith et al.,
2001). H11 is a family of microsomal aminopeptidases for which
five isoforms have been identified in native extracts (Munn et al.,
1997; Roberts et al., 2013), and several related isoforms recently
found from genomic and transcriptomic analysis (Mohandas
et al., 2016). H-gal-GP is a 1,000 kDa complex of four zinc metal-
lopeptidases (MEP1-4) and two pepsinogen-like aspartyl proteases
(PEP-1 and PEP-2) (Smith et al., 2003), together with additional
components (thrombospondin, galectins and cystatin), thought
unlikely to be protective (Knox et al., 2003). Vaccination of sheep
with either H11 or H-gal-GP individually reduced worm burdens
and faecal egg counts (FECs) by 70% and 95%, respectively (Munn
et al., 1997; Newton and Munn, 1999; Knox et al., 2003;
LeJambre et al., 2008; Roberts et al., 2013). Cysteine proteases
HmCP-1, 4 and 6, enriched from adult H. contortus gut membrane,
provided a lower level of protection (Knox et al., 2005). Barbervax
induces circulating antibodies which are ingested by the parasite
when it feeds and which inhibit haemoglobinase activity in vitro
(Ekoja and Smith, 2010) and probably in vivo. Because the gut-
membrane antigens are not exposed to the host immune system
during natural infection, Barbervax relies on the induction of anti-
bodies to ‘‘hidden” antigens (Knox et al., 2003). Therefore, it is
speculated that the Barbervax proteins are not under selective
pressure during natural infection, but whether vaccine-induced
immunity influences levels of gene expression is currently
unknown.
The high level of genetic diversity observed in genomic datasets
of H. contortus (Laing et al., 2013) and other helminths underpins
their capacity for adaptation and contributes to the evolution of
drug resistance (Gilleard and Redman, 2016). It is clear that patho-
gens can evolve in response to other interventions including vacci-
nation, in some cases leading to vaccine escape and failure
(Brueggemann et al., 2007; Kennedy and Read, 2017). Given the
limited number of antigens composing the H. contortus vaccine,
selection may arise in the field. Here we compare the transcrip-
tomes of Haemonchus adults surviving in Barbervax vaccinated
animals with worms recovered from control animals post chal-
lenge infection. Identifying any effects that vaccines may have on
helminth populations may guide their optimal use in the field.2. Materials and methods
2.1. Experimental design and collection of parasite material
Adult worms examined in this study were collected on comple-
tion of a Barbervax vaccine trial carried out at the Moredun
Research Institute, UK. Twelve 6-month old worm-free Texel cross
lambs were allocated into groups of six, balanced for sex and
weight. One group was injected s.c. with two doses of Barbervax
4 weeks apart, whilst the second, control group was not vacci-nated. All sheep were given a challenge infection of 5,000 H. contor-
tus MHco3(ISE) L3s administered per os on the same day as the
second vaccination. The MHco3(ISE) strain is susceptible to all
broad-spectrum anthelmintics (Roos et al., 2004) and was inbred
to produce the material for the H. contortus genome sequencing
project at the Wellcome Trust Sanger Institute, UK (Laing et al.,
2013). All strains were maintained at the Moredun Research Insti-
tute, UK. The same H. contortusMHco3(ISE) strain was used to gen-
erate the vaccine for this study and to challenge vaccinated and
control lambs.
FECs were monitored twice weekly between days 17 and 29
post-challenge by a McMaster technique (MAFF, 1986) with a sen-
sitivity of 50 eggs/g. Adult worms were recovered from each sheep
at post-mortem 31 days post-challenge. Antibody titres were mea-
sured by ELISA, with plates coated with Barbervax (50 ll per well
at 2 lg/ml). Serum samples were serially diluted (from 1/100 to
1/51200) in PBS/0.5% Tween and binding detected using mouse
anti-sheep IgG (Clone GT-34, Sigma, UK, G2904; 1:2500 dilution)
and rabbit anti-mouse IgG-Horse Radish Peroxidase (HRP) conju-
gate (Dako, Denmark, P0260; 1:1000 dilution). Antibody titres
are expressed as the reciprocal of the end-point dilution resulting
in an O.D. of 0.1 above the average negative control value.
2.2. Ethics statement
Experimental infections were performed at the Moredun
Research Institute as described previously (Laing et al., 2013). All
experimental procedures were examined and approved by the
Moredun Research Institute Experiments and Ethics Committee
(MRI E46 11) and were conducted under approved UK Home Office
licence (PPL 60/03899) in accordance with the 1986 Animals (Sci-
entific Procedures) Act.
2.3. Extraction protocol, library preparation and sequencing
To avoid any confounding factors from eggs in females or differ-
ences in sex ratio between samples, only male worms were used
for RNA sequencing. RNA sequencing was carried out on pools of
10 surviving H. contortus adult worms from each animal. Due to
the vaccine efficacy, only seven worms were available for sequenc-
ing in two vaccinated sheep (V_1 and V_6, Supplementary
Table S1). In total, 54 worms that survived following challenge
infection of the Barbervax vaccinated sheep (V group) and 60
worms from control sheep (C group) were selected for RNA prepa-
rations (Supplementary Table S1).
Total RNA was extracted from the worms using a standard Tri-
zol (Thermo Fisher Scientific, UK, 15596026) protocol and libraries
prepared with the Illumina TruSeq RNA preparation kit before
sequencing using a HiSeq 2500 platform with v3 chemistry.
2.4. Quantitative reverse transcription PCR (qRT-PCR)
Total RNA was extracted from triplicate samples of five female
worms from the same populations as the sequenced males. Total
RNA (3 lg) was used per oligo(dT) cDNA synthesis (SuperScript
III First-Strand Synthesis System, ThermoFisher, UK, 18080051)
with no-reverse transcriptase controls included for each sample.
cDNA was diluted 1:100 for quantitative reverse transcription-
PCR (qRT-PCR) and 1 ml added to each reaction. qRT-PCR was car-
ried out following the Brilliant III Ultra Fast SYBR QPCR Master
Mix protocol (Agilent Technologies, UK, 600882) and results anal-
ysed using MxPro qPCR Software, Version 4.10. Gene expression
was normalised to ama (HCOI01464300) and gpd (HCOI01760600)
(Lecova et al., 2015). Primer sequences are listed in Supplementary
Table S2.
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The H. contortus MHco3.ISE reference genome assembly used
for this study was a snapshot of the latest version as of 14 Novem-
ber, 2014. This assembly consists of 6,668 scaffolds with a total
assembly length of 332,877,166 bp; of which 22,769,937 bp are
sequence gaps. The N50 scaffold length is 5,236,391 bp and N90
length is 30,845 bp. Specifically for this project, preliminary gene
models were annotated on this assembly by transferring the gene
models from the published (v1.0) genome assembly (Laing et al.,
2013) using RATT (Otto et al., 2011) with default parameters, and
with a de novo approach using Augustus v2.6.1 (Stanke et al.,
2004) with exon boundary ’hints’ from the RNAseq data described
previously (Laing et al., 2013), mapped against the new reference
genome in the same way as in this previous paper.2.6. RNAseq data handling and differential expression analysis
RNAseq data were mapped onto the reference genome using a
gene index built with Bowtie2 (Langmead and Salzberg, 2012)
and TopHat v2.1.0 (Trapnell et al., 2009) with a maximal intron
length of 50 Kbp and an inner mate distance of 30 bp that identi-
fied 48.8% of the reads being mapped unambiguously to a gene fea-
ture. Counts of reads spanning annotated gene features were
subsequently determined with HTSeq v0.6.0 (Anders et al., 2015).
To ensure our biological conclusions are not sensitive to details
of the statistical methods used, we implemented two different
analysis frameworks for the RNA-seq count data, using the DESeq2
v1.12.4 framework (Love et al., 2014) and the voom function as
implemented in the LIMMA package v3.28.21 (Law et al., 2014)
in R v3.3.1 (R Core Team, 2016. R: A Language and Environment
for Statistical Computing. R Foundation for Statistical Computing,
Vienna, Austria). Genes found to be significantly differentially
expressed (DE, adjusted P value <5%) by both voom and DESeq2
analyses were retained. A gene ontology (GO) enrichment analysis
was performed using the TopGO package v2.26.0 (Alexa, A., Rah-
nenfuhrer, J., 2016. topGO: Enrichment Analysis for Gene Ontol-
ogy; http://bioconductor.org/packages/release/bioc/html/topGO.
html). Any adjusted P < 0.05 was considered significant.
Gene identifiers of the vaccine core components, namely MEP-3
(Smith et al., 2000), MEP-1,2,4, PEP-1 (Britton et al., 1999) and PEP-
2 (Smith et al., 2003) as well as H11, were retrieved via a BLAST
search of their nucleotide sequence against the H. contortus
MHco3.ISE reference assembly (Laing et al., 2013) in WormBase
ParaSite (Howe et al., 2017). The expression levels of candidate
housekeeping genes (Lecova et al., 2015) were also retrieved using
the gene identifiers associated with their GenBank records
(Table 1).3. Results
3.1. Vaccination greatly reduces FECs in vaccinated sheep
Parasitological data confirmed a significant reduction in H. con-
tortus infection following Barbervax vaccination. Over the course of
the trial, vaccinated sheep (group V) shed significantly fewer eggs
(mean 390 ± 639 eggs per gram faeces (epg), Fig. 1A, Supplemen-
tary Table S1) than the control group (group C) given the same
challenge infection dose without prior vaccination (mean 5,914 ±
2,628 epg), representing a 15-fold decrease (Wilcoxon test, P =
0.002). Vaccinated sheep contained fewer worms, indicated by
the significantly lower worm volume collected at necropsy com-
pared with control sheep (2.8 mL ± 1.9 versus 6.7 mL ± 3.5; Supple-
mentary Table S1). Among the V group, V_5 showed an outlying
egg excretion over the course of the trial (1,647 epg at necropsy;upper 95% confidence interval (CI) limit of 861 epg estimated after
1,000 bootstraps), suggesting a relatively suboptimal vaccine
response in this animal. This is supported by the lower antibody
titre of this sheep, relative to the other Barbervax vaccinated ani-
mals, at day 28 post challenge infection (Fig. 1B).3.2. Transcriptional response of worms to host vaccination is
dominated by higher expression of proteases and protease inhibitors
We investigated any changes in H. contortus gene expression in
worms surviving in vaccinated sheep relative to those surviving in
controls. On average 11 million (S.D. of 1.79 million) reads were
available for each library (Supplementary Table S1). In Principal
component analysis (PCA) of the normalized RNA-seq read counts,
the first two axes explained 53% of the total variation, 37% of which
was resolved along the first axis that separated the experimental
groups (Supplementary Fig. S1). Two pools of worms sampled from
control sheep, C_4 and C_6, showed atypical behaviour that was
resolved along the second PCA axis (Supplementary Fig. S1). These
samples were discarded from the dataset for subsequent analyses,
resulting in a comparison of six V samples and four C samples.
We found 52 genes significantly DE (adjusted P value <0.05)
between the two experimental groups, with six genes exhibiting
a fold change above 4 (Fig. 2), and 34 genes showing a fold change
above 2 (Supplementary Fig. S2, Table 1, Supplementary Table S3).
Adult worm survival following vaccination was associated with an
increase in expression of most of the DE genes, i.e. 46 out of 52.
Among the top six DE genes, the only down-regulated gene was
a glycoside hydrolase domain-containing protein (HCOI00569100,
Table 1, Fig. 2A). Three of the most highly up-regulated genes
encoded proteins containing peptidase domains (HCOI01945600,
HCOI01283800, Table 1, Fig. 2A) and a peptidase inhibitor I4
domain (HCOI01549900, Table 1, Fig. 2A), while two genes were
unannotated (HCOI01623600, HCOI01736400). Noticeably, ortho-
logs of HCOI01736400 in D. viviparus (nDv.1.0.1.g04423) or Ancy-
lostoma caninum (ANCCAN_06626 and ANCCAN_06627) also
encoded cathepsin B (cysteine peptidase). Expression of the pepti-
dases (HCOI01945600, HCOI01283800) and HCOI01736400 was
validated by qRT-PCR in female worms from the same population
as the sequenced males; this confirmed a two to threefold greater
expression of each mRNA also in female worms surviving in vacci-
nated sheep compared with controls (Fig. 2B).
Most of the top six DE genes generally exhibited low transcript
counts in group C populations (Supplementary Table S4), suggest-
ing that their higher expression in worms from group V may be
triggered or selected for by the vaccine exposure. Interestingly,
14 genes among the 52 DE gene set encoded peptidases or pepti-
dase inhibitors exemplified by the significant enrichment for pep-
tidase activity (P = 6.7  1015), serine-type (P = 9.6  108) and
cysteine-type peptidase (P = 2.8  1010) GO terms (Supplemen-
tary Table S5). This shift toward peptidase activity is also consis-
tent with down-regulation of the gamma IFN-inducible
lysosomal thiol reductase (GILT, HCOI02049600, Supplementary
Table S3), which is known to catalyse the reduction of cysteine
proteases.
Higher expression of two genes involved in the antimicrobial
response, the Lys-8 encoding gene (HCOI00041100) associated
with lysozyme formation, and the antimicrobial peptide thero-
macin coding gene (HCOI00456500), was also found in worms sur-
viving in vaccinated animals. A proteinase inhibitor
(HCOI01591500) and a prolyl-carboxypeptidase encoding gene
(HCOI01624100) showing 99.6% similarity with contortin 2 (Gen-
Bank accession number CAM84574.1, BLASTP, e-value = 0) also
showed significantly greater expression in the V group (Supple-
mentary Table S3).
Table 1
Gene of interest expression levels, fold change (FC) and associated P values measured in Haemonchus contortus recovered from vaccinated and control sheep.
Gene ID Mean
Counta
logFCb
DESeq2
adj. Pc
DESeq2
logFCb
voom
adj. Pc
voom
Correlation
with FEC29d
WormBase ParaSite Gene Description Caenorhabditis
elegans
orthologue
Candidate
Gene
Name
GenBank
Acc.
Number
Top
differentially
expressed
(DE)
HCOI00569100 24.21 2.39 2.40E13 5.16 4.55E03 0.63 (0.05) Glycoside hydrolase domain containing protein [U6P060] n/a n/a n/a
HCOI01945600 2000.03 2.02 2.33E16 2.39 9.83E04 0.64 (0.05) Peptidase A1 domain containing protein [U6PP66] pcl, Bace n/a n/a
HCOI01623600 23.12 2.03 2.05E09 4.21 6.77E03 0.79 (0.01) n/a n/a n/a n/a
HCOI01283800 38840.11 2.15 3.58E15 2.79 1.28E03 0.76 (0.01) Peptidase C1A domain containing protein [U6P6R9] CtsB1 n/a n/a
HCOI01549900 1104.78 2.20 6.42E16 2.86 1.31E03 0.73 (0.02) Protease inhibitor I4 domain containing protein [U6PNP0] srp-1,2,3,6,7,8 n/a n/a
HCOI01736400 2678.92 2.49 4.60E31 3.01 7.91E05 0.81
(0.004)
n/a CtsB1 n/a n/a
Vaccine Antigen HCOI01993300 4049.71 0.30 3.09E01 0.32 3.46E01 n/a Propeptide domain containing protein [U6PXI5] n/a pep-2 AJ577754.1
HCOI01993500 13499.65 0.34 2.65E01 0.35 3.06E01 n/a Propeptide and Peptidase A1 domain containing protein
[U6PQD5]
n/a pep-1 AF079402.1
HCOI00348800 8859.39 0.47 1.56E02 0.51 1.14E01 n/a Peptidase M13 domain containing protein [U6NMI3] n/a mep-2 AF080117.1
HCOI01333400 9325.90 0.59 3.88E02 0.62 1.64E01 n/a Peptidase M13 domain containing protein [U6PHP6] nep-9, nep-20 mep-3 AF080172.1
HCOI02032800 2207.13 0.71 1.25E02 0.90 5.97E02 n/a Peptidase M1 domain containing protein [U6PYE0] T07F10.1 h11 FJ481146.1
HCOI00308300 18250.90 0.73 4.82E04 0.78 5.85E02 n/a Peptidase M13 domain containing protein [U6NME0] mep-1 AF102130.1
HCOI00631000 5690.45 0.77 2.40E04 0.81 5.97E02 n/a mep-4 AF132519.1
Housekeeping
genes
HCOI00909100 5753.25 0.41 5.29E01 0.60 3.93E01 n/a Nematode fatty acid retinoid binding domain containing
protein [U6NYW0]
n/a far CDJ86885.1
HCOI00117100 1379.12 0.08 9.64E01 0.07 7.96E01 n/a Superoxide dismutase [Cu-Zn] [U6NGP5] n/a sod CDJ80830.1
HCOI01760600 24868.64 0.08 8.59E01 0.08 7.92E01 n/a Glyceraldehyde-3-phosphate dehydrogenase (inferred by
orthology to a human protein) [Source:UniProtKB;Acc:
P04406]
n/a gpd CDJ92718.1
HCOI01743600 194.02 0.13 9.13E01 0.14 7.28E01 n/a RNA recognition motif domain containing protein [U6NLP1] n/a ncbp CDJ82645.1
HCOI01464300 974.31 0.32 3.24E01 0.35 3.06E01 n/a DNA-directed RNA polymerase [U6PFA6] n/a ama CDJ91461.1
a Mean count indicates the mean transcript count across the pools.
b log-FC in expression as measured by DeSeq2 or voom accordingly.
c P values adjusted for multiple testing.
d Correlation between transcript expression level and faecal egg count (FEC) at 29 day p.i.
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Fig. 1. Faecal egg counts (FEC) and anti-Barbervax IgG titer of individual sheep. (A) FEC from each of the 12 sheep in the trial were plotted for each available time point post
challenge. The plot shows a 15-fold difference in egg excretion between vaccinated and control sheep on day 29 post challenge infection. Dots for V_1, V_3 and V_4 overlap
around 0 as a result of low counts. (B) FEC measured at necropsy, plotted against respective anti-Barbervax vaccine IgG titer, showing a negative correlation between vaccine
response and egg count.
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differential expression analysis was also performed without this
sample (Supplementary Table S6). This produced a reduced list of
only 13 DE genes due to a loss of power. However, the 12 most
highly DE genes reported herein were also identified when using
the reduced dataset, supporting the robustness of our analysis
(Supplementary Table S6).
3.3. Vaccine antigen coding genes are not DE between experimental
groups
Importantly we found that most of the genes encoding the core
components of the Barbervax vaccine (MEPs, PEPs, Aminopepti-
dases) were not significantly DE between V and C worms or where
significant, showed slight over-expression in the V worm popula-
tion (Table 1, Fig. 3). Notably, no transcripts were found for the
pep1.2 gene (Fig. 3).
4. Discussion
In comparison with the development of drug resistance, vaccine
resistance has rarely been reported in viruses or bacteria (Kennedy
and Read, 2017). These contrasting findings may relate both to the
prophylactic use of vaccines, which prevent the spread of resistant
mutants among hosts, and the multiplicity of pathways targeted by
the host immune response following vaccination (Kennedy andRead, 2017). However, highly diverse populations such as H. con-
tortus (Gilleard and Redman, 2016) likely encompass a wide range
of genotypes that could be differentially selected, ultimately lead-
ing to vaccine resistance through replacement (Martcheva et al.,
2008; Weinberger et al., 2011; Barnett et al., 2015).
Resistance to all but the newest anthelmintic drugs is common
and widespread amongst GIN parasites of ruminants. Barbervax,
which is specific for H. contortus, is the only vaccine registered
for a gut dwelling nematode of any host. While this vaccine pro-
vides a useful level of protection mediated mainly by reducing pas-
ture contamination, a small proportion of worms do survive
vaccination. Here, we investigated whether the transcriptome of
these survivors differed from those of control worms.
In order to generate enough genetic material for sequencing and
to avoid any contamination by egg-specific transcripts, this study
focused on male worms only. Consequently, our experiment could
not resolve the observed sex-specific effect of the Barbervax vac-
cine, i.e. the vaccine being more efficient on females than males
(Smith and Smith, 1993), although we were able to confirm some
of the observed transcriptional differences in female worms recov-
ered from the same animals. Our data shed light on transcription
modifications involved in the survival of male worms and provided
insights into the mechanisms associated with their survival follow-
ing vaccination.
Since both experimental groups exhibited similar levels of vac-
cine antigen transcripts, there was no evidence for increased
Fig. 2. Expression level of the top differentially expressed genes within each experimental group (A) and as measured by quantitative reverse transcription PCR (qRT-PCR) in
adult female worms (B). (A) A boxplot for all six genes that exhibited an absolute log-transformed fold change (FC) of 2 between the experimental conditions. dcp, domain
containing protein.(B) Fold change in expression level of selected genes, by qRT-PCR, shown relative to the control population (C). qRT-PCR was carried out on RNA extracted
from adult female worms. HCOI01283800, peptidase C1A domain containing protein; HCOI01549900, protease inhibitor I4 domain containing protein; HCOI01736400,
ortholog to cathepsin B in Dictyocaulus viviparus and Ancylostoma caninum.
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vival. However a metallopeptidase and an exopeptidase, belonging
to the same functional families (Rawlings et al., 2010) as the vac-
cine MEP (M13 peptidase) and H11 (M1 peptidase) respectively,
were over-expressed in the vaccine survivors although it is not
clear whether these could compensate for vaccine peptidases. A
prolyl-carboxypeptidase gene with a high degree of similarity to
contortin was also upregulated in worms surviving vaccination.
Contortin was initially considered to be a protective protein, how-
ever subsequent work identified aminopeptidase H11, with which
contortin co-purified, as the major protective component (Smith
and Munn, 1990). Although contortin has been detected in Barber-
vax using sensitive proteomics, its contribution to the antigenic
cocktail is thought to be minimal due to the enrichment proce-
dures for the H11 and H-Gal-GP fractions during the vaccine prepa-
ration (unpublished data). Its anticoagulant properties (Geldhof
and Knox, 2008) could. However. contribute to worm survival by
increasing their feeding ability. Instead, survival following Barber-
vax vaccination was associated with enhanced expression of a
limited subset of genes, mainly encoding cysteine peptidases. Dif-
ferential tuning of a GILT-like gene, i.e. down-regulated in worms
surviving the vaccine response, would also support proteolytic
function as an important feature for vaccine survival, as this pleio-
tropic gene is known to modulate cysteine protease activity and
stability (Rausch and Hastings, 2015). In addition, there was an
indication of higher selection pressure on a lyst-1 orthologue, aregulator of endosomal trafficking in Caenorhabditis elegans polar-
ized epithelial cells (de Souza et al., 2007), that may share the same
function in H. contortus and thus contribute to efficient processing
of protein material from the intestinal lumen. This suggests that
regulation of the proteolytic pathways in vaccine survivors may
result in improved survival. While the precise function of cysteine
peptidases is hard to infer in silico, current knowledge from in vitro
studies points to their role in the proteolytic cascade responsible
for degrading haemoglobin or immunoglobulin G (Williamson
et al., 2003). Perhaps worms that over-express these proteins
may either maintain blood coagulation and digestion, or are able
to degrade host IgG stimulated by the vaccine challenge (Munn
et al., 1997; Ekoja and Smith, 2010) to evade the vaccine response,
or some combination of both. Indeed the vaccine is proposed to
disrupt digestion in the worm gut by blocking the function of the
intestinal proteases it targets. Processing of ingested proteins by
an alternative proteolytic pathway may improve the survival
and/or fecundity of worms suffering dietary restriction. In addition,
the over-expression of a myo-inositol-1 phosphate synthase in
vaccine survivors may also support this theory as this gene is
known to act on lipid storage (Ashrafi et al., 2003) and in the defe-
cation cycle (Tokuoka et al., 2008), both critical in the digestion
process, and hence impacting worm growth and lifespan.
Interestingly, the most highly differentially expressed genes
show a low level of expression in worms from the control group,
suggesting that the vaccine response may have induced their over-
Fig. 3. Expression level for the vaccine antigen coding genes. The normalized transcript counts for known vaccine antigen coding genes are shown. Each dot stands for the
transcript count measured in a pool of worms from vaccinated (V, green dots) or control (C, red dots) sheep. Some of the dots overlap because of similar expression levels. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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cine selects for natural variation in expression of these genes. Addi-
tional transcriptomic evaluation of the offspring of each worm
subpopulation, before and after vaccine exposure, would help con-
firm this observation and distinguish between a regulatory
response to vaccine-induced immunity and genetic differences
influencing gene expression.
Whilst this study focuses on a species of veterinary significance,
our findings may have relevance to other species. Indeed our
results suggest that H. contortus may be able to compensate for
vaccine-mediated immunity after vaccine exposure and a similar
situation may apply in other parasitic nematode systems.
In conclusion, our data suggest that parasite populations surviv-
ing Barbervax immunisation are able to optimize their proteolytic
machinery, involving both peptidases and regulators of lysosome
trafficking, and display better lipid storage and/or defecation abil-
ities which may enhance survival in the face of a robust vaccine-induced immune response. While our experiment was not
designed to detect genetic selection to the vaccine response, an
‘‘evolve and resequence” approach to contrast changes in allele fre-
quencies in vaccinated and unvaccinated populations through
time, across multiple generations of vaccine challenge, could help
resolve the potential for adaptation following vaccination.
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